Massachusetts General Hospital ( Site 1162) — Boston, Massachusetts

Massachusetts General Hospital ( Site 1162) is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital ( Site 1162) has participated in 1 clinical trials.

Therapeutic areas: Carcinoma, Squamous Cell, Skin Neoplasms.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital ( Site 1162)?

Massachusetts General Hospital ( Site 1162) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital ( Site 1162) conducted?

Massachusetts General Hospital ( Site 1162) has 1 clinical trials on record. Their work covers Carcinoma, Squamous Cell, Skin Neoplasms.

Is Massachusetts General Hospital ( Site 1162) accredited by Crixeo Health?

Massachusetts General Hospital ( Site 1162) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital ( Site 1162)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.